Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
One of greatest challenges to the successful treatment of cancer is drug resistance. An exciting approach is the eradication of cancer stem cells (CSCs). However, little is known about key signals regulating the formation and expansion of CSCs. Moreover, lack of a reliable predictive preclinical model has been a major obstacle to discover new cancer drugs and predict their clinical activity. Here, in ovarian cancer, a highly chemoresistant tumor that is rapidly fatal, we provide the first evidence demonstrating the causal involvement of mechanical stimulus in the CSC phenotype using a customizable microfluidic platform and three-dimensional spheroids, which most closely mimic tumor behavior. We found that ovarian cancer cells significantly acquired the expression of epithelial-to-mesenchymal transition and CSC markers and a remarkable chemoresistance to clinically relevant doses of frontline chemotherapeutic drugs cisplatin and paclitaxel when grown under fluid shear stress, which corroborates with the physiological attainable levels in the malignant ascites, but not under static condition. Furthermore, we uncovered a new link of microRNA-199a-3p, phosphatidylinositol 3-kinase/Akt and multidrug transporter activation in shear stress-induced CSC enrichment. Our findings shed new light on the significance of hydrodynamics in cancer progression, emphasizing the need of a flow-informed framework in the development of therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It was found that fluid shear stress could prompt ovarian cancer cell dissemination, enrich cancer stem cell population as well as enhance tumor's chemoresistance to anti-cancer drugs.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [156]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [115]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [115]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293
Bapat, S. A., Mali, A. M., Koppikar, C. B., & Kurrey, N. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3931 · Cited by 760
Szotek, P. P., Pieretti-Vanmarcke, R., Masiakos, P. T., Dinulescu, D. M., Connolly, D., Foster, R., Dombkowski, D., Preffer, F., MacLaughlin, D. T., & Donahoe, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603672103 · Cited by 751
PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.
Pu, X., & Xu, X. (2015) · Europe PMC (PubMed Central) · Cited by 453
HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells
Knuefermann, C., Lu, Y., Liu, B., Jin, W., Liang, K., Wu, L., Schmidt, M., Mills, G. B., Mendelsohn, J., & Fan, Z. (2003) · Oncogene · doi:10.1038/sj.onc.1206394 · Cited by 452
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
Kumar, S. M., Liu, S., Lu, H., Zhang, H., Zhang, P. J., Gimotty, P. A., Guerra, M., Guo, W., & Xu, X. (2012) · Oncogene · doi:10.1038/onc.2011.656 · Cited by 308
Myungjin Lee, J., Mhawech-Fauceglia, P., Lee, N., Cristina Parsanian, L., Gail Lin, Y., Andrew Gayther, S., & Lawrenson, K. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.41 · Cited by 301
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
Hu, L., McArthur, C., & Jaffe, R. B. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605626 · Cited by 296
Peng, S., Maihle, N. J., & Huang, Y. (2010) · Oncogene · doi:10.1038/onc.2009.500 · Cited by 250
Rizvi, I., Gurkan, U. A., Tasoglu, S., Alagic, N., Celli, J. P., Mensah, L. B., Mai, Z., Demirci, U., & Hasan, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216989110 · Cited by 234
Chau, W. K., Ip, C. K., Mak, A. S. C., Lai, H.-C., & Wong, A. S. T. (2013) · Oncogene · doi:10.1038/onc.2012.290 · Cited by 220
Self-citationPhenotypic heterogeneity and instability of human ovarian tumor-initiating cells
Stewart, J. M., Shaw, P. A., Gedye, C., Bernardini, M. Q., Neel, B. G., & Ailles, L. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005529108 · Cited by 209
OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway
Wang, Y.-D., Cai, N., Wu, X.-L., Cao, H.-Z., Xie, L.-L., & Zheng, P.-S. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.272 · Cited by 178
Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth
Wang, K.-C., Garmire, L. X., Young, A., Nguyen, P., Trinh, A., Subramaniam, S., Wang, N., Shyy, J. Y., Li, Y.-S., & Chien, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914825107 · Cited by 172
The Role of MicroRNAs in Ovarian Cancer
Kinose, Y., Sawada, K., Nakamura, K., & Kimura, T. (2014) · BioMed Research International · doi:10.1155/2014/249393 · Cited by 164
Serra, M., Brito, C., Sousa, M. F. Q., Jensen, J., Tostões, R. M., Clemente, J. J., Strehl, R., Hyllner, J., Carrondo, M. J. T., & Alves, P. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.06.015 · Cited by 150
Guan, Y., Yang, X., Wei, L., & Chen, Q. (2011) · The FASEB Journal · doi:10.1096/fj.11-185132 · Cited by 140
CD133 expression associated with poor prognosis in ovarian cancer
Zhang, J., Guo, X. Q., Chang, D. Y., Rosen, D. G., Mercado‐Uribe, I., & Liu, J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.170 · Cited by 137
Roles and Mechanism of miR-199a and miR-125b in Tumor Angiogenesis
He, J., Jing, Y., Li, W., Qian, X., Xu, Q., Li, F.-S., Liu, L.-Z., Jiang, B., & Jiang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056647 · Cited by 127
The role of microRNAs in the regulation of cancer stem cells
Takahashi, R.-U., Miyazaki, H., & Ochiya, T. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2013.00295 · Cited by 118
Schmandt, R. E., Broaddus, R. R., Lu, K. H., Shvartsman, H. S., Thornton, A., Malpica, A. L., Sun, C. C., Bodurka, D. C., & Gershenson, D. M. (2003) · Cancer · doi:10.1002/cncr.11561 · Cited by 106
HCELL Is the Major E- and L-selectin Ligand Expressed on LS174T Colon Carcinoma Cells
Burdick, M. M., Chu, J. T., Godar, S., & Sackstein, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513617200 · Cited by 98
Flow Characterization of a Spinner Flask for Induced Pluripotent Stem Cell Culture Application
Ismadi, M.-Z., Gupta, P., Fouras, A., Verma, P., Jadhav, S., Bellare, J., & Hourigan, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106493 · Cited by 93
Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation.
Nagy, J. A., Herzberg, K. T., Dvorak, J. M., & Dvorak, H. F. (1993) · PubMed · Cited by 93
Stordal, B., Hamon, M., McEneaney, V., Roche, S., Gillet, J., O’Leary, J. J., Gottesman, M. M., & CLYNES, M. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040717 · Cited by 89
Hamaï, A., Meslin, F., Benlalam, H., Jalil, A., Mehrpour, M., Faure, F., Lecluse, Y., Vielh, P., Avril, M.-F., Robert, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0719 · Cited by 81
Yu, W., Qu, H., Hu, G., Zhang, Q., Song, K., Guan, H., Liu, T., & Qin, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089966 · Cited by 80
The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma
Kinose, Y., Sawada, K., Nakamura, K., Sawada, I., Toda, A., Nakatsuka, E., Hashimoto, K., Mabuchi, S., Takahashi, K., Kurachi, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3604 · Cited by 78
Perfusion cultures of human embryonic stem cells
Fong, W. J., Tan, H. L., Choo, A. B. H., & Oh, S. K. W. (2005) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-005-0421-5 · Cited by 68
Fluid-Flow Induced Wall Shear Stress and Epithelial Ovarian Cancer Peritoneal Spreading
Avraham-Chakim, L., Elad, D., Zaretsky, U., Kloog, Y., Jaffa, A., & Grisaru, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060965 · Cited by 67
Gareau, T., Lara, G. G., Shepherd, R. D., Krawetz, R., Rancourt, D. E., Rinker, K. D., & Kallos, M. S. (2014) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1518 · Cited by 65
Raspollini, M. R., Amunni, G., Villanucci, A., Baroni, G., Taddei, A., & Taddei, G. L. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh139 · Cited by 64
Regulation of Metastasis by microRNAs in Ovarian Cancer
Wang, Y., Kim, S., & Kim, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00143 · Cited by 56
Optimization of flowrate for expansion of human embryonic stem cells in perfusion microbioreactors
Titmarsh, D., Hidalgo, A., Turner, J., Wolvetang, E., & Cooper‐White, J. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23260 · Cited by 52
Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.
Makhija, S., Taylor, D. D., Gibb, R. K., & Gerçel-Taylor, C. (1999) · International Journal of Oncology · doi:10.3892/ijo.14.3.515 · Cited by 51
Lane, W. O., Jantzen, A. E., Carlon, T. A., Jamiolkowski, R. M., Grenet, J. E., Ley, M. M., Haseltine, J., Galinat, L. J., Lin, F., Allen, J. D., et al. (2012) · Journal of Visualized Experiments · doi:10.3791/3349 · Cited by 51
Brustmann, H. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.04.035 · Cited by 47
Botta, G. P., Manley, P., Miller, S., & Lelkes, P. I. (2006) · Nature Protocols · doi:10.1038/nprot.2006.311 · Cited by 30
Ashworth, A., Balkwill, F. R., Bast, R. C., Berek, J. S., Kaye, A., Boyd, J. A., Mills, G. B., Weinstein, J. N., Woolley, K., & Workman, P. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.11.014 · Cited by 26
Abstract 2472: Peritoneal mechanobiology and metastatic success in epithelial ovarian cancer
Burkhalter, R. J., Liu, Y., Marszow, M., Sun, Z., Meininger, G. A., Wagner, D. R., & Stack, M. S. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-2472 · Cited by 1
Research works printed but not linked: 1
- White, F. M. Viscous fluid flow. 2nd edn, Ch. 3, 104–211 (McGraw-Hill, 1974).
Cited by
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Chen, S.-H., & Chang, J.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174136 · Cited by 428
Moshksayan, K., Kashaninejad, N., Warkiani, M. E., Lock, J. G., Moghadas, H., Firoozabadi, B., Saidi, M. S., & Nguyen, N.-T. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.01.223 · Cited by 267
The Untapped Potential of Ascites in Ovarian Cancer Research and Treatment
Ford, C. E., Werner, B., Hacker, N. F., & Warton, K. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0875-x · Cited by 261
“There is also broader evidence that ascites is involved in promoting epithelial-to-mesenchymal transition (EMT), by shifting cancer cells towards a stem-cell-like phenotype.(38,51,52) Cancer stem cells have the capacity to self-renew and differentiate, reducing their vulnerability to chemotherapy, especially in sphero…”
Loret, N., Denys, H., Tummers, P., & Berx, G. (2019) · Cancers · doi:10.3390/cancers11060838 · Cited by 247
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Metadata
- Authors
- Ip, C. K. M., Li, S.-S., Tang, M. Y. H., Sy, S. K. H., Ren, Y., Shum, H. C., & Wong, A. S. T.
- Affiliations
- University of Hong Kong (HK)
- University of Nottingham Ningbo China (CN)
- Corresponding author
- Shum, Ho Cheung
- Wong, Alice S. T.
- Venue
- Scientific Reports
- Published
- 2016-06-01
- Volume
- 6
- Issue
- 1
- Pages
- 26788-26788
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4887794
- OpenAlex
- W2411989512
- Semantic Scholar
- 3de6a4bc8956ea6c48d1d158c7368c0ae7adc0aa
- Cited by
- 128
- References
- 43
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 13 · 2023: 15 · 2022: 25 · 2021: 12 · 2020: 9 · 2019: 16 · 2018: 16 · 2017: 5 · 2016: 1
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- Nottingham ePrints (University of Nottingham) (submittedVersion, cc-by-nc-nd)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- Chinese University of Hong Kong
- NYU Polytechnic School of Engineering
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- epithelial ovarian cancer, cancer stem cells, chemoresistance, fluid shear stress, mechanical stimulation, epithelial-mesenchymal transition, cisplatin resistance, paclitaxel resistance, PI3K/Akt signaling, multidrug transporter, multicellular spheroids, microfluidic platform, malignant ascites
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Animals, Ascites, Carcinoma, Female, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Proteins, Ovarian Neoplasms, RNA, Neoplasm, Tumor Cells, Cultured, Neoplastic Stem Cells, Signal Transduction, Spheroids, Cellular, Drug Resistance, Neoplasm, ATP Binding Cassette Transporter, Subfamily B, Member 1, Shear Strength, MicroRNAs, Mice, Lab-On-A-Chip Devices, Hydrodynamics, Epithelial-Mesenchymal Transition, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.